← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2011Last known activity
Dec 31, 2020
Defunct as of Dec 31, 2025
Timeline
2000s
- Jun 1, 2008
OncoSec Medical Incorporated— Founded
2020s
- Dec 31, 2025
OncoSec Medical Incorporated— Defunct
Drugs by trial phase (8 distinct, 10 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT04627675CollaboratorPhase 1Dec 31, 2020
- NCT04526730CollaboratorPhase 2Aug 20, 2020
- NCT03823131CollaboratorPhase 2Feb 1, 2019
- NCT03567720Lead sponsorPhase 2Aug 31, 2018
- NCT03567720Study directorPhase 2Aug 31, 2018
- NCT03132675Study directorPhase 2Oct 3, 2017
- NCT03132675Lead sponsorPhase 2Oct 3, 2017
- NCT02531425Lead sponsorPhase 1Sep 1, 2015
- NCT02345330Lead sponsorPhase 2May 1, 2015
- NCT01579318Lead sponsorPhase 2Jul 1, 2012
- NCT01502293Lead sponsorPhase 2Dec 1, 2011
- NCT01440816Lead sponsorPhase 2Nov 1, 2011
Details
- Founded
- San Diego, CA, US Jun 1, 2008
- Last known activity
- Dec 31, 2020